BSE · 543520
Global Longlife Hospital and Research Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹0 Cr with net profit ₹-2 Cr — a -33067.31% net margin, versus 3.55% the period before.
Shareholding
As of 2026-06-30
- Promoter22.88%
- Public77.12%
1,133 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 2.97× from low to high.
Risk flags
Derived from disclosed data
- Under exchange surveillance — LT-ASM · ASM 1. Trading may carry price bands, periodic call auction or higher margins.
Peer comparison
Healthcare · ranked #53 of 79 by market cap · medians across 50 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Apollo Hospitals Enter. Limited | ₹1,28,543 Cr | 242.8 | 13.56 | 20.48% | 7.7% |
| Max Healthcare Institute Ltd. | ₹1,10,230 Cr | 74.32 | 10.26 | 13.42% | 17.23% |
| Fortis Healthcare Ltd. | ₹71,797 Cr | 270.17 | 7.26 | 10.53% | 11.41% |
| Aster DM Healthcare Ltd. | ₹42,716 Cr | 303.11 | 9.34 | 8.48% | 8.36% |
| Narayana Hrudayalaya Ltd. | ₹42,523 Cr | 50.71 | 9.37 | 17.76% | 10.2% |
| Global Health Limited | ₹38,168 Cr | 264.85 | 9.63 | 14.05% | 12.62% |
| Krishna Institute of Medical Sciences Ltd. | ₹34,012 Cr | 137.02 | 9.08 | 10.74% | 6.18% |
| Dr. Lal Path Labs Ltd. | ₹31,767 Cr | 241.09 | 12.66 | 20.13% | 18.27% |
| Poly Medicure Ltd. | ₹16,957 Cr | 51.81 | 5.46 | 10.37% | 17.18% |
| Dr. Agarwal's Health Care Limited | ₹15,478 Cr | 390.64 | 7.64 | 6.58% | 6.4% |
| Global Longlife Hospital and Research Ltd.(this company) | ₹12 Cr | — | 0.52 | -7.24% | 0% |
AI analysis
AI-generated · google/gemini-2.5-flashGlobal Longlife Hospital and Research Ltd. has a market capitalization of Rs 12 Cr. The company reported revenue of Rs 0.01 Cr and a negative profit margin of 0%. Its 52-week trading range is Rs 9 to Rs 26.73.
Positives
- +The company has a negligible debt-to-equity ratio of 0.
- +Promoter pledge is 0%, indicating no shares pledged by the promoters.
- +The number of shareholders has increased from 7 in November 2021 to 1149 in March 2026.
Negatives
- −Revenue significantly declined from Rs 5.59 Cr in March 2025 to Rs 0.01 Cr in March 2026.
- −The company reported a negative Return on Equity (ROE) of -7.24% and Return on Capital Employed (ROCE) of -4.1589%.
- −Net profit decreased from Rs 0.1987 Cr in March 2025 to a loss of Rs -1.7195 Cr in March 2026.
- −Promoter shareholding has decreased from 54.2856% in March 2023 to 22.8761% in March 2026.
- −The earnings per share (EPS) for March 2026 is negative at -1.64.
- −Quarterly results have not been disclosed since March 2023.
Financial performance
The company's revenue has seen a significant decline, falling from Rs 5.5934 Cr in March 2025 to Rs 0.0052 Cr in March 2026. Net profit also decreased, from Rs 0.1987 Cr in March 2025 to a loss of Rs -1.7195 Cr in March 2026. Earnings per share (EPS) were negative at -1.64 in March 2026.
Profitability & returns
Global Longlife Hospital and Research Ltd. has experienced negative profitability. The Return on Equity (ROE) is -7.24% and Return on Capital Employed (ROCE) is -4.1589%. The company's profit margin stands at 0%. EBITDA also turned negative, recorded at -0.9877 in March 2026.
Balance sheet
The company's debt to equity ratio is 0, indicating no debt. Book value per share is Rs 22.62. No dividend yield is reported.
Ownership & pledges
As of March 31, 2026, promoter holding stands at 22.8761%, while public shareholding is 77.1239%. There are no shares pledged by the promoters. The number of shareholders as of the latest disclosure is 1149.
Regulatory & surveillance
The company is not currently under any surveillance measure.
Data as of — price: 2026-07-30 · financials: Mar 26 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.
Back to Global Longlife Hospital and Research Ltd.share price & fundamentals